Resolution and resurgence of Schistosoma haematobium-induced pathology after community-based chemotherapy in Ghana, as detected by ultrasound

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1515-1522

  Wagatsuma, Yukiko ^a,b,c,d   Aryeetey, Mary E ^a,b,c   Sack, David A ^a,b,c   Morrow, Richard H ^a,b,c   Hatz, Christoph ^a,b,c   Kojima, Somei ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Ghana   (Ghana)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d JAPAN INTERNATIONAL COOPERATION AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ARTICLE; COST EFFECTIVENESS ANALYSIS; CYSTITIS; ENDEMIC DISEASE; GHANA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; ULTRASOUND; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANIMALS; CHILD; CHILD, PRESCHOOL; COMMUNITY MEDICINE; FEMALE; FOLLOW-UP STUDIES; GHANA; HUMANS; MALE; PRAZIQUANTEL; RECURRENCE; RURAL POPULATION; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMICIDES; URINARY BLADDER; WORLD HEALTH ORGANIZATION;

EID: 0033034958     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314786     Document Type: Article

References (28)

1. 1. World Health Organization. The Control of Schistosomiasis. Report of a WHO Expert Committee. 728. 1985. Geneva. World Health Organ Tech Rep Ser.
2. 2. World Health Organization. The Control of Schistosomiasis. Report of a WHO Expert Committee. 830. 1993. Geneva. World Health Organ Tech Rep Ser.
3. 3. Scott D, Senker K, England EC. Epidemiology of human Schistosoma haematobium infection around Volta Lake, Ghana, 1973-75. Bull World Health Organ 1982;60:89-100.
4. 4. Hatz C, Savioli L, Mayombana C, Dhunputh J, Kisumku UM, Tanner M. Measurement of schistosomiasis-related morbidity at community level in areas of different endemicity. Bull World Health Organ 1990;68:777-87.
5. 5. Hatz CF, Vennervald BJ, Nkulila T, et al. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg 1998;59:775-81.
6. 6. Cairo Working Group. Edited by Jenkins JM, Hatz C. The use of diagnostic ultrasound in schistosomiasis attempts at standardization of methodology. Acta Trop 1992;51:45-63.
7. 7. Degremont A, Burki A, Burnier E, Schweizer W, Meudt R, Tanner M. Value of ultrasonography in investigating morbidity due to Schistosoma haematobium infection. Lancet 1985;1:662-5.
8. 8. Dittrich M, Doehring E. Ultrasonographical aspects of urinary schistosomiasis: assessment of morphological lesions in the upper and lower urinary tract. Pediatr Radiol 1986;16:225-30.
9. 9. Doehring E, Ehrich JH, Reider F, et al. Morbidity in urinary schistosomiasis: relation between sonographical lesions and pathological urine findings. Trop Med Parasitol 1985;36:145-9.
10. 10. Hatz C, Mayombana C, de Savigny D, MacPherson CN, Koella JCXDA, Tanner M. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel. Trans R Soc Trop Med Hyg 1990;84:84-8.
11. 11. Heurtier Y, Lamothe F, Develoux M, Docquier J, Mouchet F, Sellin EXSB. Urinary tract lesions due to Schistosoma haematobium infection assessed by ultrasonography in a community based study in Niger. Am J Trop Med Hyg 1986;35:1163-72.
12. 12. Hatz C, Jenkins JM, Morrow RH, Tanner M. Ultrasound in schistosomiasis - a critical look at methodological issues and potential applications. Acta Trop 1992;51:89-97.
13. 13. Doehring-Schwerdtfeger E, Kardorff R. Ultrasonography in schistosomiasis in Africa, Mem Inst Oswaldo Cruz 1995;90:141-5.
14. 14. World Health Organization, Meeting on ultrasonography in schistosomiasis. Proposal for a practical guide to the standardized use of ultrasound in the assessment of pathological changes. TDR/SCH/ULTRASON/91.3. 1991, Geneva.
15. 15. World Health Organization. Urine filtration technique for S. haematobium infection. PDP/83.3. 1983, Geneva.
16. 16. World Health Organization. The role of chemotherapy in schistosomiasis control. WHO/SCHISTO/83.70. 1983. Geneva.
17. 17. Guyatt HL, Smith T, Gryscels B, et al. Aggregation in schistosomiasis: comparison of the relationships between prevalence and intensity in different endemic areas. Parasitology 1994;109:45-55.
18. 18. Doehring E, Ehrich JH, Bremer HJ. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection. Kidney Int 1986;30: 582-5.
19. 19. Doehring E, Reider F, Schmidt-Ehry G, Ehrich JH. Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with praziquantel. J Infect Dis 1985;152: 807-10.
20. 20. Devidas A, Lamothe F, Develoux M, Mouchet F, Sellin B. Ultrasonographic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel. Ann Soc Belg Med Trop 1989;69:57-65.
21. 21. King CH, Lombardi G, Lombardi C, et al. Chemotherapy-based control of schistosomiasis haematobia. 1. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 1988;39: 295-305.
22. 22. King CH, Muchiri EM, Ouma JH. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations. Mem Inst Oswaldo Cruz 1992;87(suppl):203-10.
23. 23. Laurent C, Lamothe F, Develoux M, Sellin B, Mouchet F. Ultrasonographic assessment of urinary tract lesions due to Schistosoma haematobium in Niger after four consecutive years of treatment with praziquantel. Trop Med Parasitol 1990;41:139-42.
24. 24. Dalton PR, Pole D. Water-contact patterns in relation to Schistosoma haematobium infection. Bull World Health Organ 1978;56:417-26.
25. 25. Warren KS. Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis 1973;127:595-609.
26. 26. Wilkins HA, Goll PH, Marshall TF, Moore PJ. Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection. Trans R Soc Trop Med Hyg 1984;78:227-32.
27. 27. Hagan P, Abath FG. Recent advances in immunity to human schistosomiasis. Mem Inst Oswaldo Cruz 1992;87(suppl):95-8.
28. 28. Hagan P. Immunity and morbidity in infection due to Schistosoma haematobium. Am J Trop Med Hyg 1996;55:116-20.